Porton Advanced: Your reliable CDMO partner in biotech, specializing in cell and gene therapy, mRNA, viral vectors, and plasmids with comprehensive GMP compliance.
Location: China, Shanghai
Employees: 201-500
Founded date: 2018
Mentions in press and media 10
| Date | Title | Description |
| 23.05.2025 | Porton Advanced: Pioneering the Future of Cell Therapy Through Strategic Collaborations | In the ever-evolving landscape of biotechnology, partnerships can be the lifeblood of innovation. Porton Advanced, a prominent contract development and manufacturing organization (CDMO), is making waves in the field of advanced therapy medi... |
| 22.05.2025 | Porton Advanced Announces Collaboration with TongEYE to Accelerate Development of iPSC-RPEC transplantation therapy | SUZHOU, China, May 22, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with TongE... |
| 19.05.2025 | Porton Advanced Announces Collaboration with Hualong Biological to Accelerate MATC Cell Therapy Development for Solid Tumor Treatment Breakthroughs | SUZHOU, China, May 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Hualo... |
| 16.04.2025 | Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy | SUZHOU, China, April 16, 2025 /PRNewswire/ -- April 12, 2025, Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has receive... |
| 19.03.2025 | Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development | CRANBURY, N.J., March 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eu... |
| 30.07.2024 | Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics | SUZHOU, China, July 30, 2024 /PRNewswire/ -- On July 29, 2024, Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Biotech&qu... |
| 25.06.2024 | Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services | SUZHOU, China, June 25, 2024 /PRNewswire/ -- Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as the first cell therapy CDMO in China to ... |
| 20.11.2023 | Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging | SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell ... |
| 09.11.2023 | Porton Advanced and BioMap Announce Strategic Partnership to Develop AAV Gene Therapy | Porton Advanced announced the establishment of a strategic partnership with BioMap. BioMap will leverage Porton Advanced’s unique Adeno-Associated Virus (AAV) vector technology platform and research data to develop AAV assembly efficiency m... |
| 08.11.2023 | Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development | SUZHOU, China, Nov. 8, 2023 /PRNewswire/ -- On November 8, 2023, Porton Advanced announced the establishment of a strategic partnership with BioMap. BioMap will leverage Porton Advanced's unique Adeno-Associated Virus (AAV) vector technolog... |